These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 25416745)
1. Combining Electrolysis and Electroporation for Tissue Ablation. Phillips M; Rubinsky L; Meir A; Raju N; Rubinsky B Technol Cancer Res Treat; 2015 Aug; 14(4):395-410. PubMed ID: 25416745 [TBL] [Abstract][Full Text] [Related]
2. Electrolytic Effects During Tissue Ablation by Electroporation. Rubinsky L; Guenther E; Mikus P; Stehling M; Rubinsky B Technol Cancer Res Treat; 2016 Oct; 15(5):NP95-NP103. PubMed ID: 26323571 [TBL] [Abstract][Full Text] [Related]
3. Synergistic Combination of Electrolysis and Electroporation for Tissue Ablation. Stehling MK; Guenther E; Mikus P; Klein N; Rubinsky L; Rubinsky B PLoS One; 2016; 11(2):e0148317. PubMed ID: 26866693 [TBL] [Abstract][Full Text] [Related]
4. Tissue Ablation by a Synergistic Combination of Electroporation and Electrolysis Delivered by a Single Pulse. Phillips M; Krishnan H; Raju N; Rubinsky B Ann Biomed Eng; 2016 Oct; 44(10):3144-3154. PubMed ID: 27146516 [TBL] [Abstract][Full Text] [Related]
5. The Enlargement of Ablation Area by Electrolytic Irreversible Electroporation (E-IRE) Using Pulsed Field with Bias DC Field. Lv Y; Liu H; Feng Z; Zhang J; Chen G; Yao C Ann Biomed Eng; 2022 Dec; 50(12):1964-1973. PubMed ID: 35852648 [TBL] [Abstract][Full Text] [Related]
6. Incorporation of Reversible Electroporation Into Electrolysis Accelerates Apoptosis for Rat Liver Tissue. Kim HB; Chung JH Technol Cancer Res Treat; 2020; 19():1533033820948051. PubMed ID: 32985353 [TBL] [Abstract][Full Text] [Related]
7. Single exponential decay waveform; a synergistic combination of electroporation and electrolysis (E2) for tissue ablation. Klein N; Guenther E; Mikus P; Stehling MK; Rubinsky B PeerJ; 2017; 5():e3190. PubMed ID: 28439465 [TBL] [Abstract][Full Text] [Related]
8. In vitro study on the mechanisms of action of electrolytic electroporation (E2). Klein N; Mercadal B; Stehling M; Ivorra A Bioelectrochemistry; 2020 Jun; 133():107482. PubMed ID: 32062417 [TBL] [Abstract][Full Text] [Related]
9. Electric field modulation in tissue electroporation with electrolytic and non-electrolytic additives. Ivorra A; Rubinsky B Bioelectrochemistry; 2007 May; 70(2):551-60. PubMed ID: 17350351 [TBL] [Abstract][Full Text] [Related]
10. Irreversible electroporation: a new ablation modality--clinical implications. Rubinsky B; Onik G; Mikus P Technol Cancer Res Treat; 2007 Feb; 6(1):37-48. PubMed ID: 17241099 [TBL] [Abstract][Full Text] [Related]
11. A Conceivable Mechanism Responsible for the Synergy of High and Low Voltage Irreversible Electroporation Pulses. Lv Y; Yao C; Rubinsky B Ann Biomed Eng; 2019 Jul; 47(7):1552-1563. PubMed ID: 30953220 [TBL] [Abstract][Full Text] [Related]
12. A 2-D Cell Layer Study on Synergistic Combinations of High-Voltage and Low-Voltage Irreversible Electroporation Pulses. Lv Y; Yao C; Rubinsky B IEEE Trans Biomed Eng; 2020 Apr; 67(4):957-965. PubMed ID: 31265380 [TBL] [Abstract][Full Text] [Related]
13. Molecular and histological study on the effects of electrolytic electroporation on the liver. Lv Y; Zhang Y; Rubinsky B Bioelectrochemistry; 2019 Feb; 125():79-89. PubMed ID: 30292929 [TBL] [Abstract][Full Text] [Related]
14. The combination of electroporation and electrolysis (E2) employing different electrode arrays for ablation of large tissue volumes. Klein N; Guenther E; Botea F; Pautov M; Dima S; Tomescu D; Popescu M; Ivorra A; Stehling M; Popescu I PLoS One; 2019; 14(8):e0221393. PubMed ID: 31437212 [TBL] [Abstract][Full Text] [Related]
15. In vivo results of a new focal tissue ablation technique: irreversible electroporation. Edd JF; Horowitz L; Davalos RV; Mir LM; Rubinsky B IEEE Trans Biomed Eng; 2006 Jul; 53(7):1409-15. PubMed ID: 16830945 [TBL] [Abstract][Full Text] [Related]
16. Electrolytic liver ablation is not associated with evidence of a systemic inflammatory response syndrome. Teague BD; Court FG; Morrison CP; Kho M; Wemyss-Holden SA; Maddern GJ Br J Surg; 2004 Feb; 91(2):178-83. PubMed ID: 14760665 [TBL] [Abstract][Full Text] [Related]
17. Toward a clinical real time tissue ablation technology: combining electroporation and electrolysis (E2). Guenther E; Klein N; Mikus P; Botea F; Pautov M; Lugnani F; Macchioro M; Popescu I; Stehling MK; Rubinsky B PeerJ; 2020; 8():e7985. PubMed ID: 31998549 [TBL] [Abstract][Full Text] [Related]
19. Preliminary Validation of Electroporation-Electrolysis (E2) for Cardiac Ablation Using a Parameterisable In-Vivo Model. Zhao L; Rasko A; Drescher C; Maleki S; Cejnar M; McEwan A Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():289-293. PubMed ID: 31945898 [TBL] [Abstract][Full Text] [Related]
20. Irreversible electroporation for the ablation of liver tumors: are we there yet? Charpentier KP Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]